Myeloid NDC Assay

Would you like to implement the new ICC, WHO, ELN and IPSS-M recommendations in your laboratory research with a single streamlined assay?

The Myeloid-NDC assay helps you to do this while using only 100ng of DNA to detect all the required genomic alterations.

Myeloid-NDC is a research use only assay intended for the integrated and qualitative detection of mutations, fusion genes/translocations and copy number variants from myeloid DNA samples.

The Myeloid-NDC assay has been designed as an integrated research tool covering most genomic alterations recommended for the genomic characterisation of acute myeloid leukaemias (AML), myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN)1-4. The Myeloid-NDC analysis application provides a simple solution to allow laboratories to perform integrated genomic research according to the newest guidelines and recommendations. The assay covers most genomic alterations recommended for the classification of acute myeloid leukaemias (ICC, WHO and ELN), myelodysplastic syndromes (IPSS-M, ICC, WHO) and myeloproliferative neoplasms (ICC, WHO).

Request a quotation

1. Introduction

2. Scope

3. Output

4. Performance

5. Publications

6. Resources

7. Enquire